Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Oncogenic ETS proteins replace activated Ras/MAPK signaling in prostate cells.


ABSTRACT: Approximately 50% of prostate cancers have chromosomal translocations resulting in the over-expression one of four ETS family transcription factors. However, it is not known why these four four family members are selected for oncogenic roles, while other ETS proteins are not. We found that the four oncogenic ETS family members have a specific role in prostate cell migration. Using chromatin immunoprecipitation coupled with next-generation sequencing, this specific biological function was matched to a specific set of genomic targets highlighted by the presence of an AP-1 binding site. ETS/AP-1 binding sites are prototypical Ras-responsive elements, but oncogenic ETS proteins could activate a Ras/MAPK transcriptional program in the absence of MAPK activation. These findings indicate that the specific function of ETS proteins over-expressed in prostate cancer is the activation of a Ras/MAPK gene expression program in the absence of signaling pathway mutations. ChIP sequencing two transcription factors in PC3 cells, four transcription factors plus a FLAG control in RWPE-1 cells and input DNA sequencing from each cell line.

ORGANISM(S): Homo sapiens

SUBMITTER: Peter Hollenhorst 

PROVIDER: E-GEOD-29808 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.

Hollenhorst Peter C PC   Ferris Mary W MW   Hull Megan A MA   Chae Heejoon H   Kim Sun S   Graves Barbara J BJ  

Genes & development 20111001 20


The aberrant expression of an oncogenic ETS transcription factor is implicated in the progression of the majority of prostate cancers, 40% of melanomas, and most cases of gastrointestinal stromal tumor and Ewing's sarcoma. Chromosomal rearrangements in prostate cancer result in overexpression of any one of four ETS transcription factors. How these four oncogenic ETS genes differ from the numerous other ETS genes expressed in normal prostate and contribute to tumor progression is not understood.  ...[more]

Similar Datasets

2011-10-19 | GSE29438 | GEO
2011-10-20 | GSE29808 | GEO
2011-10-18 | E-GEOD-29438 | biostudies-arrayexpress
| PRJNA140921 | ENA
| PRJNA141513 | ENA
2018-05-05 | GSE114054 | GEO
2022-08-12 | PXD023593 | Pride
2012-02-28 | E-GEOD-34839 | biostudies-arrayexpress
2010-06-09 | E-GEOD-14206 | biostudies-arrayexpress
2012-06-05 | GSE23197 | GEO